Following difficult recent months for EQRx, the biotech is being bought by Revolution Medicines in an all-stock transaction that secures $1 billion in additional capital for the oncology company.
Form 425 EQRx, Inc Filed by: EQRx, Inc streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Operator: Good afternoon and welcome to the EQRx First Quarter 2023 Financial Results Conference Call. Please be advised that this conference call is being recorded.